France Endoscopy Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

The France Endoscopy Devices Market size is estimated at USD 2.14 billion in 2024, and is expected to reach USD 3.13 billion by 2029, growing at a CAGR of 7.77% during the forecast period (2024-2029).

COVID-19 had a significant impact on the market studied in France. A May 2022 published study by PubMed states that without any catch-up outside of the lockdown periods and despite the gradual rollout of the national COVID-19 vaccine campaign in 2021, the pandemic had a significant negative impact on hospitalizations for cataract surgery, coronary angioplasty, hip and knee arthroplasties, and other procedures from 2020 through the first half of 2021. The hospital care given to surgical patients was unavoidably impacted by the pandemic. Pre-hospital emergency departments, critical care units, and anesthesia departments were notably impacted. The hospital system underwent a significant change as resources were transferred to the care of COVID-19 patients. Hence, it is observed that the endoscopy devices market was majorly hampered during the COVID-19 pandemic.

The demand for various endoscopy devices is anticipated to increase due to various factors, including rising demand for surgeries with faster recovery and the increasing adoption of endoscopy for treatment and diagnosis. Additionally, the rising burden of chronic diseases such as cancer is propelling the growth of the market studied. For instance, according to Globocan 2020, the incidence of pancreatic cancer in France was 14,461, and liver cancer was 11,504. These cases are expected to increase in the future, which is anticipated to propel the market's growth in France.

Additionally, the presence of French-born companies in the endoscopy business is propelling the growth of the market as local endoscopy devices are sold at a lesser cost compared to imported devices. Furthermore, due to the presence of key players such as Fujifilm, Conmed Corporation, Boston Scientific, and Medtronic PLC, there is a strong availability of branded endoscopy devices in the country. Therefore, owing to the above-mentioned factors, the market studied is expected to witness strong growth over the forecast period.

However, the lack of skilled labor in the country may hinder the market's growth over the forecast period.

France Endoscopy Devices Market Trends

Cardiology is Expected to Witness Strong Growth Over the Forecast Period

Applications of endoscopy devices in cardiology are expected to increase and contribute to the growth of the market studied in the coming years. This is majorly attributed to the increasing prevalence of cardiovascular diseases across the country.

As per the data published in 2022 by Foundation De France, every four minutes, a person from France faces a cardiovascular event. These conditions are currently France's second-leading cause of death and are affecting younger segments of the population. The Foundation de France has been funding research to better understand, anticipate, and treat cardiovascular problems for more than 20 years. With the presence of such organizations in the country, awareness about cardiovascular diseases (CVD), and their related treatment options, the market is anticipated to witness significant growth in France over the forecast period.

Obesity in the country is fueling the number of people suffering from CVD. For instance, as per the Foundation De France 2022 data, around 17% of the young people in France are obese, and a large share of these people have cardiovascular diseases. According to the article published in November 2021, there were around 94,408 cases of cardiovascular diseases and interventions in 2020 in France. This high number of cardiac disease patients is propelling the market's growth.

Hence, with the increasing burden of cardiovascular diseases in France, the segment is likely to witness strong growth over the forecast period.

High Prevalence of Diseases that Require Endoscopy is also Contributing to the Market's Growth

The increase in incidences of chronic diseases is the main factor responsible for the market's growth in the historical and forecast periods. In France, researchers have made several efforts to cope with various respiratory diseases that are idiopathic. For instance, according to the data from the Respiratory Medicine and Research Journal published in August 2022, the management of diseases such as idiopathic pulmonary fibrosis has evolved significantly in France in recent years. This is majorly attributed to the improved guidelines on disease diagnosis and treatment coupled with effective disease management practices in the country. Hence, with the efforts of French researchers in enabling effective diagnostic methods for idiopathic pulmonary diseases, it is believed that there will be a growing demand for endoscopy devices which will boost the market's growth in the coming years.

Furthermore, according to the PubMed data published in September 2022, in the randomized study of patients with mild to moderate dysplasia across 17 French hospitals, it was observed that people with dysplasia are at a higher risk of developing lung cancer over time. In addition, bronchoscopy was found to be useful for risk stratification strategies in lung cancer screening programs. Therefore, the use of bronchoscopy is increasing among patients with long-term dysplasia in France. Thus, with the effectiveness of bronchoscopes in lung cancer screening, the segment is expected to witness strong growth during the forecast period.

France Endoscopy Devices Industry Overview

The endoscopy devices market in France consists of several major players. The companies are implementing certain strategic initiatives, such as mergers and acquisitions, new product launches, and partnerships, that help them in strengthening their market position. Some of the key companies present in the market include Boston Scientific Corporation, Conmed Corporation, Medtronic PLC, Johnson & Johnson, and Fujifilm Holding Corporation, among others.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

This product will be delivered within 2 business days.